Perillyl Alcohol Modulates Activation, Permeability and Integrity of Human Brain Endothelial Cells Induced by Plasmodium Falciparum

Overview

Journal Mem Inst Oswaldo Cruz

Specialties Parasitology
Tropical Medicine

Date 2023 Jul 5

PMID 37403869

Authors

Adriana A Marin

Annette Juillard

Alejandro M Katzin

Leonardo Jm Carvalho

Georges Er Grau

Affiliations

Soon will be listed here.

Abstract

Background: Cerebral malaria (CM) is a severe immunovasculopathy caused for Plasmodium falciparum infection, which is characterised by the sequestration of parasitised red blood cells (pRBCs) in brain microvessels. Previous studies have shown that some terpenes, such as perillyl alcohol (POH), exhibit a marked efficacy in preventing cerebrovascular inflammation, breakdown of the brain-blood barrier (BBB) and brain leucocyte accumulation in experimental CM models.

Objective: To analyse the effects of POH on the endothelium using human brain endothelial cell (HBEC) monolayers co-cultured with pRBCs.

Methodology: The loss of tight junction proteins (TJPs) and features of endothelial activation, such as ICAM-1 and VCAM-1 expression were evaluated by quantitative immunofluorescence. Microvesicle (MV) release by HBEC upon stimulation by P. falciparum was evaluated by flow cytometry. Finally, the capacity of POH to revert P. falciparum-induced HBEC monolayer permeability was examined by monitoring trans-endothelial electrical resistance (TEER).

Findings: POH significantly prevented pRBCs-induced endothelial adhesion molecule (ICAM-1, VCAM-1) upregulation and MV release by HBEC, improved their trans-endothelial resistance, and restored their distribution of TJPs such as VE-cadherin, Occludin, and JAM-A.

Conclusions: POH is a potent monoterpene that is efficient in preventing P. falciparum-pRBCs-induced changes in HBEC, namely their activation, increased permeability and alterations of integrity, all parameters of relevance to CM pathogenesis.

References

Grau G, Craig A . Cerebral malaria pathogenesis: revisiting parasite and host contributions. Future Microbiol. 2012; 7(2):291-302. DOI: 10.2217/fmb.11.155. View

Pais T, Penha-Goncalves C . Brain Endothelium: The "Innate Immunity Response Hypothesis" in Cerebral Malaria Pathogenesis. Front Immunol. 2019; 9:3100. PMC: 6361776. DOI: 10.3389/fimmu.2018.03100. View

Grau G, Piguet P, Vassalli P, Lambert P . Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev. 1989; 112:49-70. DOI: 10.1111/j.1600-065x.1989.tb00552.x. View

McCloy R, Rogers S, Caldon C, Lorca T, Castro A, Burgess A . Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. Cell Cycle. 2014; 13(9):1400-12. PMC: 4050138. DOI: 10.4161/cc.28401. View

Carvalho L, Ferreira-da-Cruz M, Daniel-Ribeiro C, Pelajo-Machado M, Lenzi H . Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malar J. 2007; 6:59. PMC: 1890294. DOI: 10.1186/1475-2875-6-59. View

Kwiatkowski D, Hill A, Sambou I, Twumasi P, Castracane J, Manogue K . TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990; 336(8725):1201-4. DOI: 10.1016/0140-6736(90)92827-5. View

Renia L, Howland S, Claser C, Gruner A, Suwanarusk R, Teo T . Cerebral malaria: mysteries at the blood-brain barrier. Virulence. 2012; 3(2):193-201. PMC: 3396698. DOI: 10.4161/viru.19013. View

Debs S, Cohen A, Hosseini-Beheshti E, Chimini G, Hunt N, Grau G . Interplay of extracellular vesicles and other players in cerebral malaria pathogenesis. Biochim Biophys Acta Gen Subj. 2018; 1863(2):325-331. DOI: 10.1016/j.bbagen.2018.10.012. View

TRAGER W, Jensen J . Human malaria parasites in continuous culture. Science. 1976; 193(4254):673-5. DOI: 10.1126/science.781840. View

10.

Rodriguez A, Carvalho L, Kimura E, Katzin A . Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria. Int J Antimicrob Agents. 2017; 51(3):370-377. DOI: 10.1016/j.ijantimicag.2017.08.025. View

11.

Thumwood C, Hunt N, Clark I, Cowden W . Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology. 1988; 96 ( Pt 3):579-89. DOI: 10.1017/s0031182000080203. View

12.

de Souza J, Riley E . Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 2002; 4(3):291-300. DOI: 10.1016/s1286-4579(02)01541-1. View

13.

Gowda D, Wu X . Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria. Front Immunol. 2019; 9:3006. PMC: 6305727. DOI: 10.3389/fimmu.2018.03006. View

14.

Combes V, Simon A, Grau G, Arnoux D, Camoin L, Sabatier F . In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999; 104(1):93-102. PMC: 408397. DOI: 10.1172/JCI4985. View

15.

Idro R, Ndiritu M, Ogutu B, Mithwani S, Maitland K, Berkley J . Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. JAMA. 2007; 297(20):2232-40. PMC: 2676709. DOI: 10.1001/jama.297.20.2232. View

16.

Barrera V, Haley M, Strangward P, Attree E, Kamiza S, Seydel K . Comparison of CD8 T Cell Accumulation in the Brain During Human and Murine Cerebral Malaria. Front Immunol. 2019; 10:1747. PMC: 6668485. DOI: 10.3389/fimmu.2019.01747. View

17.

Grisendi G, Finetti E, Manganaro D, Cordova N, Montagnani G, Spano C . Detection of microparticles from human red blood cells by multiparametric flow cytometry. Blood Transfus. 2014; 13(2):274-80. PMC: 4385076. DOI: 10.2450/2014.0136-14. View

18.

Grau G, Mackenzie C, Carr R, Redard M, Pizzolato G, Allasia C . Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis. 2003; 187(3):461-6. DOI: 10.1086/367960. View

19.

Brown H, Hien T, Day N, Mai N, Chuong L, Chau T . Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999; 25(4):331-40. DOI: 10.1046/j.1365-2990.1999.00188.x. View

20.

Moreira A, Estato V, Malvar D, Sanches G, Gomes F, Tibirica E . L-arginine supplementation and thromboxane synthase inhibition increases cerebral blood flow in experimental cerebral malaria. Sci Rep. 2019; 9(1):13621. PMC: 6754365. DOI: 10.1038/s41598-019-49855-x. View